UK Next Steps: What to Expect from Post-Brexit Device Oversight

article image

MHRA device chief Graeme Tunbridge is excited about regulatory reforms that are on the horizon once the UK fully separates from the EU. Here are the key elements he expects to see in the new UK framework, leveraging practices in the EU, US, and other systems from around the world.

Brexit has been a source of anxiety for many in the UK since the 2016 referendum favoring the country’s exit from the EU, but as the official separation date approaches, UK device regulators appear eager for the shift, ready to build a new oversight framework that could combine elements of the current EU, US, and other global systems.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: